Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Subscribe
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
financials
Pharma
WuXi Biologics stays the course with positive 2024 outlook
Amid a national-security-related reckoning in the U.S., Chinese contract manufacturer WuXi Biologics is accentuating the positive.
Fraiser Kansteiner
Mar 27, 2024 1:44pm
WuXi AppTec presents optimistic guidance amid US security row
Mar 19, 2024 4:27pm
After a pause, Aurobindo resumes drug shipments from India plant
Mar 13, 2024 3:40pm
Despite solid pharma growth, Merck KGaA sees total sales decline
Mar 7, 2024 3:32pm
Catalent cites impairment charge for quarterly earnings delay
Nov 14, 2023 9:55am
Takeda takes $770M in write-downs amid Alofisel, Exkivity woes
Oct 26, 2023 12:27pm
